Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of KPNβ1 in neuro-oncology.
Lilley M, Farassati F. Lilley M, et al. Among authors: farassati f. Onco Targets Ther. 2017 Apr 10;10:2067-2068. doi: 10.2147/OTT.S136247. eCollection 2017. Onco Targets Ther. 2017. PMID: 28435297 Free PMC article. No abstract available.
Cancer stem cells, the ultimate targets in cancer therapy.
Shabbir A, Esfandyari T, Farassati F. Shabbir A, et al. Among authors: farassati f. Onco Targets Ther. 2018 Jan 3;11:183-184. doi: 10.2147/OTT.S154431. eCollection 2018. Onco Targets Ther. 2018. PMID: 29379299 Free PMC article. No abstract available.
Ezh2, a novel target in detection and therapy of breast cancer.
Pourakbar S, Pluard TJ, Accurso AD, Farassati F. Pourakbar S, et al. Among authors: farassati f. Onco Targets Ther. 2017 May 22;10:2685-2687. doi: 10.2147/OTT.S138777. eCollection 2017. Onco Targets Ther. 2017. PMID: 28579806 Free PMC article. No abstract available.
Targeting Cancer Stem Cells by Oncolytic Viruses and Nano-Mediated Delivery.
Hosseini M, Farassati FS, Farassati F. Hosseini M, et al. Among authors: farassati f, farassati fs. Onco Targets Ther. 2020 Sep 22;13:9349-9350. doi: 10.2147/OTT.S279639. eCollection 2020. Onco Targets Ther. 2020. PMID: 33061422 Free PMC article. No abstract available.
Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran.
Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S. Dolatkhah R, et al. Among authors: farassati f. Onco Targets Ther. 2016 Dec 7;9:7385-7395. doi: 10.2147/OTT.S116373. eCollection 2016. Onco Targets Ther. 2016. PMID: 27994469 Free PMC article.
Ral signaling pathway in health and cancer.
Moghadam AR, Patrad E, Tafsiri E, Peng W, Fangman B, Pluard TJ, Accurso A, Salacz M, Shah K, Ricke B, Bi D, Kimura K, Graves L, Najad MK, Dolatkhah R, Sanaat Z, Yazdi M, Tavakolinia N, Mazani M, Amani M, Ghavami S, Gartell R, Reilly C, Naima Z, Esfandyari T, Farassati F. Moghadam AR, et al. Among authors: farassati f. Cancer Med. 2017 Dec;6(12):2998-3013. doi: 10.1002/cam4.1105. Epub 2017 Oct 18. Cancer Med. 2017. PMID: 29047224 Free PMC article. Review.
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
Wang K, Bodempudi V, Liu Z, Borrego-Diaz E, Yamoutpoor F, Meyer A, Woo RA, Pan W, Dudek AZ, Olyaee MS, Esfandyari T, Farassati F. Wang K, et al. Among authors: farassati f. PLoS One. 2012;7(4):e33214. doi: 10.1371/journal.pone.0033214. Epub 2012 Apr 2. PLoS One. 2012. PMID: 22485139 Free PMC article.
39 results